ANNE GERSHON
Medical Practice in New York, NY
License number
Pennsylvania MD021948E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
New York, NY 10028
Pennsylvania
Pennsylvania
Personal information
See more information about ANNE GERSHON at radaris.comName
Address
Phone
176 E 93Rd St, New York, NY 10128
377 Sky Farm Rd #1, Copake, NY 12516
176 E 93Rd St, New York, NY 10128
650 168Th St, New York, NY 10032
650 W 168Th St, New York, NY 10032
Organization information
See more information about ANNE GERSHON at bizstanding.comPediatric Infectious Diseases
650 W 168 St, New York, NY 10032
Industry:
Medical Doctor's Office
Doing business as:
Pediatric Infectious Diseases - Anne A Gershon MD
Phone:
(212) 305-1556 (Phone)
Medical Doctor:
Alysse Wurcel (Medical Doctor)
Categories:
Pediatrics Physicians & Surgeons, Physicians & Surgeons
Anne Gershon MD
650 W 168 St, New York, NY 10032
Industry:
Pediatrician, Internist
Phone:
(212) 305-9445 (Phone)
Anne A. Gershon
Professional information
Anne Gershon, New York NY
Work:
Newyork-Presbyterian Morgan Stanley Children's Hospital
3959 Broadway, New York, NY 10032 Columbia University
650 W 168Th St, New York, NY 10032 New York Presbyterian Hospital / Columbia
630 W 168Th St, New York, NY 10032
3959 Broadway, New York, NY 10032 Columbia University
650 W 168Th St, New York, NY 10032 New York Presbyterian Hospital / Columbia
630 W 168Th St, New York, NY 10032
Professor Of Pediatrics At Columbia University
Position:
Professor of Pediatrics at Columbia University
Location:
Greater New York City Area
Industry:
Higher Education
Work:
Columbia University
-
Professor of Pediatrics
Dr. Anne Gershon, New York NY - MD (Doctor of Medicine)
Specialties:
Pediatric Infectious Disease Medicine
Address:
Columbia Presbyterian Medical Center
650 W 168Th St SUITE BB4, New York 10032
(212) 305-4558 (Phone)
650 W 168Th St SUITE BB4, New York 10032
(212) 305-4558 (Phone)
Certifications:
Pediatric Infectious Disease Medicine, 2002, Pediatrics, 1969
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Joan Sanford I Weill Medical College Of Cornell University
Graduated: 1964
New York Hospital
Graduated: 1965
Graduated: 1968
New York University Med Center
Graduated: 1970
Joan Sanford I Weill Medical College Of Cornell University
Graduated: 1964
New York Hospital
Graduated: 1965
Graduated: 1968
New York University Med Center
Graduated: 1970
Anne Gershon, New York NY
Specialties:
Pediatrician
Address:
622 W 168Th St, New York, NY 10032
3959 Broadway, New York, NY 10032
3959 Broadway, New York, NY 10032
Vzv Orf29P Protein-Related Compositions And Methods
US Patent:
2001003, Nov 8, 2001
Filed:
Jan 25, 2001
Appl. No.:
09/769699
Inventors:
Saul Silverstein - Irvington NY, US
Paula Annunziato - Larchmont NY, US
Anne Gershon - New York NY, US
Octavian Lungu - New York NY, US
Paula Annunziato - Larchmont NY, US
Anne Gershon - New York NY, US
Octavian Lungu - New York NY, US
International Classification:
A61K048/00, C07H021/04, C12N015/63, C12N015/85
US Classification:
435/455000, 514/044000, 536/023200
Abstract:
The present invention provides compositions of matter comprising 29p protein having bound thereto an agent whose delivery into a eukaryotic cell is desired. The present invention also provides a monoclonal antibody which specifically binds to 29p protein. The present invention further provides methods for delivering an agent into a eukaryotic cell, and methods for causing a eukaryotic cell to secrete a desired protein in the form of a fusion protein. The present invention further provides 29p protein-containing pharmaceutical compositions. The present invention still further provides nucleic acid molecules which hybridize to at least a portion of a nucleic acid molecule encoding 29p protein. Finally, the present invention provides methods for detecting the presence of, and quantitatively determining the amount of, a 29p protein-encoding nucleic acid molecule in a sample.
Genetically Engineered Cell Lines And Systems For Propagating Varicella Zoster Virus And Methods Of Use Thereof
US Patent:
2008027, Nov 13, 2008
Filed:
Sep 24, 2007
Appl. No.:
11/903708
Inventors:
Michael D. Gershon - New York NY, US
Zhenglun Zhu - Allston MA, US
Saul Silverstein - Irvington NY, US
Anne A. Gershon - New York NY, US
Zhenglun Zhu - Allston MA, US
Saul Silverstein - Irvington NY, US
Anne A. Gershon - New York NY, US
Assignee:
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK - New York NY
International Classification:
A61K 39/12, C12N 7/00, C12Q 1/70
US Classification:
4242041, 4352351, 435 5
Abstract:
The present invention provides genetically engineered cell lines, recombinant vectors, and vaccines. The present invention also provides methods for generating an in vitro system for virus (VZV), and the in vitro systems generated by these methods. The present invention further provides methods for reactivating VZV, and VZV reactivated by these methods. Finally, the present invention provides a method of screening for an agent for treating VZV infection.
Genetically Engineered Cell Lines And Systems For Propagating Virus And Methods Of Use Thereof
US Patent:
7273616, Sep 25, 2007
Filed:
May 12, 2003
Appl. No.:
10/436706
Inventors:
Jason J. Chen - New York NY, US
Anne A. Gershon - New York NY, US
Zhenglun Zhu - Worcester MA, US
Saul Silverstein - New York NY, US
Michael D. Gershon - New York NY, US
Anne A. Gershon - New York NY, US
Zhenglun Zhu - Worcester MA, US
Saul Silverstein - New York NY, US
Michael D. Gershon - New York NY, US
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61K 39/12
US Classification:
4242041, 4241991, 435 911, 435325, 4352351
Abstract:
The present invention provides genetically engineered cell lines, recombinant vectors, and vaccines. The present invention also provides methods for generating an in vitro system for Varicella zoster virus (VZV), and the in vitro systems generated by these methods. The present invention further provides methods for reactivating VZV, and VZV reactivated by these methods. Finally, the present invention provides a method of screening for an agent for treating VZV infection.